This page is part of the HL7 FHIR Implementation Guide: minimal Common Oncology Data Elements (mCODE) Release 1 - US Realm | STU1 (v4.0.0-ballot: STU4 Ballot 1) based on FHIR (HL7® FHIR® Standard) R4. The current version which supersedes this version is 3.0.0. For a full list of available versions, see the Directory of published versions
Generated Narrative: MedicationAdministration
Resource MedicationAdministration "cancer-related-medication-admin-cyclophosphamide-jenny-m"
Procedure Intent Extension: Curative - procedure intent (qualifier value) (SNOMED CT#373808002)
status: completed
category: Outpatient (MedicationRequest Category Codes#outpatient)
medication: cyclophosphamide (RxNorm#3002)
subject: Patient/cancer-patient-jenny-m " M"
effective: 2018-04-22
Actor |
Practitioner/us-core-practitioner-nancy-oncology-nurse " NURSE" |
reasonReference: Condition/primary-cancer-condition-jenny-m
note: cyclophosphamide (60 mg/m² IV), 932.59 mg in 50 ml 0.9% normal saline administered by continuous infusion. Patient tolerated infusion without side effects. (By Practitioner/us-core-practitioner-nancy-oncology-nurse @2018-04-22)
Route | Dose |
Intravenous route (qualifier value) (SNOMED CT#47625008) | 932.59 mg (Details: UCUM code mg = 'mg') |